I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase II trial of gemcitabine plus UFT as salvage treatment..:
Lee, Keun-Wook
;
Kim, Yu Jung
;
Lee, Kyung-Hun
...
Cancer Chemotherapy and Pharmacology, Vol.74 No.3, pp.447-455. , 2020
Link:
https://hdl.handle.net/10371/173022
RT Journal T1
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_173022&Exemplar=1&LAN=DE A1 Lee, Keun-Wook A1 Kim, Yu Jung A1 Lee, Kyung-Hun A1 Han, Sae-Won A1 Kim, Tae-Yong A1 Oh, Do-Youn A1 Im, Seock-Ah A1 Kim, Tae-You A1 Bang, Yung-Jue A1 Choi, In Sil A1 Kim, Jee Hyun PB Springer Verlag YR 2020 K1 INTRAVENOUS FLUOROURACIL K1 ORAL CAPECITABINE K1 LEUCOVORIN K1 CHEMOTHERAPY K1 CETUXIMAB K1 SURVIVAL K1 EFFICACY K1 INFUSION K1 BENEFIT K1 KRAS K1 Metastatic colorectal cancer K1 Refractory K1 Gemcitabine K1 UFT JF Cancer Chemotherapy and Pharmacology, Vol.74 No.3, pp.447-455 LK http://dx.doi.org/https://hdl.handle.net/10371/173022 DO https://hdl.handle.net/10371/173022 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)